The American Chamber of Commerce of the Philippines (AmCham) on Tuesday urged for stronger programs for diagnosis and ...

The Food and Drug Administration granted accelerated approval on Wednesday for a new drug developed by researchers at the ...

Dr. Charles M. Rudin highlighted new small cell lung cancer therapies, including T cell engagers, antibody-drug conjugates, ...

Researchers at Texas A&M University model extreme conditions using 3D bioprinting, revealing insights that could make flight ...

Sac-TMT combined with Keytruda significantly improves progression-free survival in PD-L1-positive advanced non-small cell ...

During the first three years of Augenstein’s lung cancer journey, he’s been happy to be able to share things he has been learning along the way.

The youth, who cannot be named for legal reasons, has 20 previous convictions for offences including, drugs, trespass, ...

A phase 3 trial evaluating a nebulized clofazimine inhalation suspension (MNKD-101) for the treatment of refractory nontuberculous mycobacterial (NTM) ...

MannKind has made the decision to discontinue the ICoN-1 Phase 3 clinical trial evaluating nebulized clofazimine inhalation ...

Langenfeld, Germany, Nov. 10, 2025 (GLOBE NEWSWIRE) -- Booking Health, a global facilitator of international medical care, announced today a timely initiative aimed at improving access to advanced ...

Please provide your email address to receive an email when new articles are posted on . New treatments for lung cancer and melanoma have significantly improved OS, but also have exacerbated ...